Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Sickle cell disease trial completes phase 3 patient enrollment

Sickle cell disease trial completes phase 3 patient enrollment

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

XTL Biopharmaceuticals purchases 4,620,356 shares of Proteologics from Teva

XTL Biopharmaceuticals purchases 4,620,356 shares of Proteologics from Teva

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Alnylam advances Tuschl II patent estate through the USPTO

Alnylam advances Tuschl II patent estate through the USPTO

Temsirolimus effective for mRCC patients on hemodialysis

Temsirolimus effective for mRCC patients on hemodialysis

Medgenics’ EPODURE Biopump technology for EPO delivery receives U.S. patent

Medgenics’ EPODURE Biopump technology for EPO delivery receives U.S. patent

Inhaled nitric oxide reduces adverse effects of stored blood transfusion in mice

Inhaled nitric oxide reduces adverse effects of stored blood transfusion in mice

Rituximab may help patients with aPL-related clinical problems

Rituximab may help patients with aPL-related clinical problems

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

Ligand Pharmaceuticals announces data from LG-7501 preclinical studies on HCV

Atpif1 gene regulates heme synthesis in red blood cell formation

Atpif1 gene regulates heme synthesis in red blood cell formation

Atpif1 gene regulates hemoglobin synthesis during red blood cell formation

Atpif1 gene regulates hemoglobin synthesis during red blood cell formation

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam third quarter 2012 revenues decrease to $16.8 million

Sapacitabine tolerated, efficacious in elderly leukemia patients

Sapacitabine tolerated, efficacious in elderly leukemia patients

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

BMJ examines debate over government program to reduce maternal mortality in India

BMJ examines debate over government program to reduce maternal mortality in India

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.